This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bühlmann, N. Articles by Born, W. Search for Related Content PubMed PubMed Citation Articles by Bühlmann, N. Articles by Born, W.

A Receptor Activity Modifying Protein (RAMP)2-Dependent Adrenomedullin Receptor Is a Calcitonin Gene-Related Peptide Receptor when Coexpressed with Human RAMP1¹

Research Laboratory for Calcium Metabolism, Departments of Orthopedic Surgery and Medicine, University of Zurich, 8008 Zurich, Switzerland

Address all correspondence and requests for reprints to: Dr. Walter Born, Klinik Balgrist, Forchstrasse 340, 8008 Zurich, Switzerland. E-mail: wborn{at}balgrist.unizh.ch

Adrenomedullin (ADM) and - and ß-calcitonin (CT) gene-related peptide (-, ßCGRP) are structurally related vasodilatory peptides with homology to CT and amylin. An originally orphan human CT receptor-like receptor (hCRLR) is a G_s protein-coupled CGRP or ADM receptor when coexpressed with recently identified human single transmembrane domain receptor activity modifying proteins 1 (hRAMP1) or -2 (hRAMP2), respectively. Here, the function of the rat CRLR homologue (rCRLR) has been investigated in rat osteoblast-like UMR-106 cells and in COS-7 cells, in the absence and presence of hRAMP1 and -2 and combinations thereof. Transient expression of rCRLR in UMR-106 cells revealed an ADM receptor, and [¹²⁵I]rat (r) ADM binding was enhanced with hRAMP2 and inhibited by 50% when hRAMP1 was coexpressed. Detectable [¹²⁵I]hCGRP binding required the presence of hRAMP1, and the expression of CGRP binding sites was unaffected by coexpressed hRAMP2. Specificity of ADM binding sites in [¹²⁵I]rADM binding inhibition experiments was reflected by an over 1000-fold higher potency of rADM [half-maximal effective concentration = 0.19 ± 0.05 nM (mean ± SEM, n = 4)], compared with rCGRP and rßCGRP, to induce a cAMP-responsive luciferase reporting gene (CRE-luc). In rCRLR and hRAMP1 cotransfected cells, expressing predominantly CGRP binding sites, rßCGRP, rCGRP, and rADM induced CRE-luc with half-maximal effective concentration of 0.27 ± 0.17 nM, 0.37 ± 0.27 nM, and 1.4 ± 0.9 nM, respectively. In COS-7 cells, the results were comparable, but rCRLR required coexpressed hRAMP2 for ADM receptor function. This is consistent with higher levels of endogenous RAMP2 encoding messenger RNA in UMR-106, compared with COS-7 cells. In conclusion, the recognition of RAMP1 and -2 as mediators of CRLR expression as a CGRP or ADM receptor has been extended, with evidence that endogenous RAMP2 is sufficient to reveal an ADM receptor in UMR-106 cells. Inhibition of RAMP2-evoked ADM receptor expression by RAMP1 and generation of a CGRP receptor is consistent with competitive interactions of the different RAMPs with rCRLR.

This article has been cited by other articles:

				Y. Xie, D. W. Wolff, M.-F. Lin, and Y. Tu Vasoactive Intestinal Peptide Transactivates the Androgen Receptor through a Protein Kinase A-Dependent Extracellular Signal-Regulated Kinase Pathway in Prostate Cancer LNCaP Cells Mol. Pharmacol., July 1, 2007; 72(1): 73 - 85. [Abstract] [Full Text] [PDF]

				Z. Zhang, C. S. Winborn, B. Marquez de Prado, and A. F. Russo Sensitization of Calcitonin Gene-Related Peptide Receptors by Receptor Activity-Modifying Protein-1 in the Trigeminal Ganglion J. Neurosci., March 7, 2007; 27(10): 2693 - 2703. [Abstract] [Full Text] [PDF]

				Y.-Y. Li, I. S.-S. Hwang, W.-S. O, and F. Tang Adrenomedullin Peptide: Gene Expression of Adrenomedullin, its Receptors and Receptor Activity Modifying Proteins, and Receptor Binding in Rat Testis--Actions on Testosterone Secretion Biol Reprod, August 1, 2006; 75(2): 183 - 188. [Abstract] [Full Text] [PDF]

				Z. Zhang, I. M. Dickerson, and A. F. Russo Calcitonin Gene-Related Peptide Receptor Activation by Receptor Activity-Modifying Protein-1 Gene Transfer to Vascular Smooth Muscle Cells Endocrinology, April 1, 2006; 147(4): 1932 - 1940. [Abstract] [Full Text] [PDF]

				C.W. Tam, K. Husmann, N.C. Clark, J.E. Clark, Z. Lazar, L.M. Ittner, J. Gotz, G. Douglas, A.D. Grant, D. Sugden, et al. Enhanced Vascular Responses to Adrenomedullin in Mice Overexpressing Receptor-Activity-Modifying Protein 2 Circ. Res., February 3, 2006; 98(2): 262 - 270. [Abstract] [Full Text] [PDF]

				T. Bouschet, S. Martin, and J. M. Henley Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane J. Cell Sci., October 15, 2005; 118(20): 4709 - 4720. [Abstract] [Full Text] [PDF]

				J. M. Bomberger, W. S. Spielman, C. S. Hall, E. J. Weinman, and N. Parameswaran Receptor Activity-modifying Protein (RAMP) Isoform-specific Regulation of Adrenomedullin Receptor Trafficking by NHERF-1 J. Biol. Chem., June 24, 2005; 280(25): 23926 - 23935. [Abstract] [Full Text] [PDF]

				E. C. Johnson, O. T. Shafer, J. S. Trigg, J. Park, D. A. Schooley, J. A. Dow, and P. H. Taghert A novel diuretic hormone receptor in Drosophila: evidence for conservation of CGRP signaling J. Exp. Biol., April 1, 2005; 208(7): 1239 - 1246. [Abstract] [Full Text] [PDF]

				J. M. Bomberger, N. Parameswaran, C. S. Hall, N. Aiyar, and W. S. Spielman Novel Function for Receptor Activity-modifying Proteins (RAMPs) in Post-endocytic Receptor Trafficking J. Biol. Chem., March 11, 2005; 280(10): 9297 - 9307. [Abstract] [Full Text] [PDF]

				D. M. Burns, L. Stehno-Bittel, and T. Kawase Calcitonin gene-related peptide elevates calcium and polarizes membrane potential in MG-63 cells by both cAMP-independent and -dependent mechanisms Am J Physiol Cell Physiol, August 1, 2004; 287(2): C457 - C467. [Abstract] [Full Text] [PDF]

				S. D. Brain and A. D. Grant Vascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin Physiol Rev, July 1, 2004; 84(3): 903 - 934. [Abstract] [Full Text] [PDF]

				S. P. Brothers, A. Cornea, J. A. Janovick, and P. M. Conn Human Loss-of-Function Gonadotropin-Releasing Hormone Receptor Mutants Retain Wild-Type Receptors in the Endoplasmic Reticulum: Molecular Basis of the Dominant-Negative Effect Mol. Endocrinol., July 1, 2004; 18(7): 1787 - 1797. [Abstract] [Full Text] [PDF]

				D. Koller, L. M. Ittner, R. Muff, K. Husmann, J. A. Fischer, and W. Born Selective Inactivation of Adrenomedullin over Calcitonin Gene-related Peptide Receptor Function by the Deletion of Amino Acids 14-20 of the Mouse Calcitonin-like Receptor J. Biol. Chem., May 7, 2004; 279(19): 20387 - 20391. [Abstract] [Full Text] [PDF]

				K. Kuwasako, Y.-N. Cao, Y. Nagoshi, T. Tsuruda, K. Kitamura, and T. Eto Characterization of the Human Calcitonin Gene-Related Peptide Receptor Subtypes Associated with Receptor Activity-Modifying Proteins Mol. Pharmacol., January 1, 2004; 65(1): 207 - 213. [Abstract] [Full Text] [PDF]

				K. Kuwasako, K. Kitamura, Y. Nagoshi, Y.-N. Cao, and T. Eto Identification of the Human Receptor Activity-modifying Protein 1 Domains Responsible for Agonist Binding Specificity J. Biol. Chem., June 13, 2003; 278(25): 22623 - 22630. [Abstract] [Full Text] [PDF]

				N. Fukai, M. Shichiri, N. Ozawa, M. Matsushita, and Y. Hirata Coexpression of Calcitonin Receptor-Like Receptor and Receptor Activity-Modifying Protein 2 or 3 Mediates the Antimigratory Effect of Adrenomedullin Endocrinology, February 1, 2003; 144(2): 447 - 453. [Abstract] [Full Text] [PDF]

				P. Hasbak, O. S. Opgaard, K. Eskesen, S. Schifter, H. Arendrup, J. Longmore, and L. Edvinsson Investigation of CGRP Receptors and Peptide Pharmacology in Human Coronary Arteries. Characterization with a Nonpeptide Antagonist J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 326 - 333. [Abstract] [Full Text] [PDF]

				S. Hippenstiel, M. Witzenrath, B. Schmeck, A. Hocke, M. Krisp, M. Krull, J. Seybold, W. Seeger, W. Rascher, H. Schutte, et al. Adrenomedullin Reduces Endothelial Hyperpermeability Circ. Res., October 4, 2002; 91(7): 618 - 625. [Abstract] [Full Text] [PDF]

				D. R. Poyner, P. M. Sexton, I. Marshall, D. M. Smith, R. Quirion, W. Born, R. Muff, J. A. Fischer, and S. M. Foord International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors Pharmacol. Rev., June 1, 2002; 54(2): 233 - 246. [Abstract] [Full Text] [PDF]

				G. S. Filippatos, N. Gangopadhyay, O. Lalude, N. Parameswaran, S. I. Said, W. Spielman, and B. D. Uhal Regulation of apoptosis by vasoactive peptides Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L749 - L761. [Abstract] [Full Text] [PDF]

				D. Naot, K. E. Callon, A. Grey, G. J. S. Cooper, I. R. Reid, and J. Cornish A Potential Role for Adrenomedullin as a Local Regulator of Bone Growth Endocrinology, May 1, 2001; 142(5): 1849 - 1857. [Abstract] [Full Text]

				N. Tilakaratne, G. Christopoulos, E. T. Zumpe, S. M. Foord, and P. M. Sexton Amylin Receptor Phenotypes Derived from Human Calcitonin Receptor/RAMP Coexpression Exhibit Pharmacological Differences Dependent on Receptor Isoform and Host Cell Environment J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 61 - 72. [Abstract] [Full Text]

				T. ESFANDYARI, W. K. MACNAUGHTON, R. QUIRION, S. ST. PIERRE, J.-L. JUNIEN, and K. A. SHARKEY A novel receptor for calcitonin gene-related peptide (CGRP) mediates secretion in the rat colon: implications for secretory function in colitis FASEB J, July 1, 2000; 14(10): 1439 - 1446. [Abstract] [Full Text]

				J. P. Hinson, S. Kapas, and D. M. Smith Adrenomedullin, a Multifunctional Regulatory Peptide Endocr. Rev., April 1, 2000; 21(2): 138 - 167. [Abstract] [Full Text]

				B. N. Evans, M. I. Rosenblatt, L. O. Mnayer, K. R. Oliver, and I. M. Dickerson CGRP-RCP, a Novel Protein Required for Signal Transduction at Calcitonin Gene-related Peptide and Adrenomedullin Receptors J. Biol. Chem., September 29, 2000; 275(40): 31438 - 31443. [Abstract] [Full Text] [PDF]

				S. Hilairet, S. M. Foord, F. H. Marshall, and M. Bouvier Protein-Protein Interaction and Not Glycosylation Determines the Binding Selectivity of Heterodimers between the Calcitonin Receptor-like Receptor and the Receptor Activity-modifying Proteins J. Biol. Chem., July 27, 2001; 276(31): 29575 - 29581. [Abstract] [Full Text] [PDF]

				K. Kuwasako, K. Kitamura, K. Ito, T. Uemura, Y. Yanagita, J. Kato, T. Sakata, and T. Eto The Seven Amino Acids of Human RAMP2 (86) and RAMP3 (59) Are Critical for Agonist Binding to Human Adrenomedullin Receptors J. Biol. Chem., December 21, 2001; 276(52): 49459 - 49465. [Abstract] [Full Text] [PDF]

				W. Nowak, N. Parameswaran, C. S. Hall, N. Aiyar, H. V. Sparks, and W. S. Spielman Novel regulation of adrenomedullin receptor by PDGF: role of receptor activity modifying protein-3 Am J Physiol Cell Physiol, June 1, 2002; 282(6): C1322 - C1331. [Abstract] [Full Text] [PDF]